Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

NCT01596699 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01596699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01596699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
May 24, 2012
Completion date
June 30, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow failure syndrome, congenital immunodeficiency, metabolic disease, myeloid malignancy, severe immune dysregulation, transfusion-dependent red blood cell (rbc) defect